Position in LLY
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$339,874,329
-$54,282,866 QoQ
Shares Held
369,521
+0.8% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 54.226688063736574.ToString("F0")%
Shared 1.061103428492562.ToString("F0")%
None 44.712208507770875.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2024CallValue
$6,790,350
CallShares
7,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026TRUIST FINANCIAL CORP holds $2,326,875,887 across 16 Drug Manufacturers - General names. LLY ranks #3 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,404,493 | $522,953,181 | |
| 2 | JNJ |
Johnson & Johnson
|
2,044,092 | $499,657,847 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
369,521 | $339,874,329 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,221,085 | $267,174,314 | |
| 5 | AZN |
Astrazeneca PLC
|
754,121 | $148,727,743 | |
| 6 | NVS |
Novartis AG
|
941,818 | $143,862,698 | |
| 7 | AMGN |
Amgen Inc
|
407,214 | $143,278,245 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,272,131 | $77,154,744 |
All Filings in LLY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $339,874,329 | 369,521 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $394,157,195 | 366,767 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $272,683,229 | 357,383 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $293,943,612 | 377,078 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $307,240,996 | 372,003 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $283,158,792 | 366,786 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $318,649,582 | 359,674 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,790,350 | 7,500 | Call | Defined | 2024-08-21 | |
| 2024-06-30 | $318,393,172 | 351,668 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $243,951,139 | 313,578 | Shares | Defined | 2024-05-13 | |
| 2024-03-31 | $5,834,700 | 7,500 | Call | Defined | 2024-05-13 | |
| 2023-12-31 | $158,573,474 | 272,033 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $165,213,665 | 307,586 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $108,986,730 | 232,391 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $83,588,771 | 243,401 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $89,310,688 | 244,125 | Shares | Defined | 2023-02-17 | |
| 2022-09-30 | $75,908,998 | 234,758 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $76,950,478 | 237,333 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $73,868,853 | 257,949 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $72,760,489 | 263,415 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $59,415,893 | 257,156 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $57,815,628 | 251,898 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $48,452,325 | 259,353 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $43,048,964 | 254,969 | Shares | Defined | 2021-11-19 | |
| 2020-09-30 | $39,324,025 | 265,667 | Shares | Defined | 2021-11-05 | |
| 2020-06-30 | $52,322,029 | 318,687 | Shares | Defined | 2021-11-16 | |
| 2020-03-31 | $42,682,338 | 307,687 | Shares | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||